TY - JOUR
T1 - Worsening of chronic heart failure
T2 - definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology
AU - Metra, Marco
AU - Tomasoni, Daniela
AU - Adamo, Marianna
AU - Bayes-Genis, Antoni
AU - Filippatos, Gerasimos
AU - Abdelhamid, Magdy
AU - Adamopoulos, Stamatis
AU - Anker, Stefan D.
AU - Antohi, Laura
AU - Böhm, Michael
AU - Braunschweig, Frieder
AU - Gal, Tuvia Ben
AU - Butler, Javed
AU - Cleland, John G.F.
AU - Cohen-Solal, Alain
AU - Damman, Kevin
AU - Gustafsson, Finn
AU - Hill, Loreena
AU - Jankowska, Ewa A.
AU - Lainscak, Mitja
AU - Lund, Lars H.
AU - McDonagh, Theresa
AU - Mebazaa, Alexandre
AU - Moura, Brenda
AU - Mullens, Wilfried
AU - Piepoli, Massimo
AU - Ponikowski, Piotr
AU - Rakisheva, Amina
AU - Ristic, Arsen
AU - Savarese, Gianluigi
AU - Seferovic, Petar
AU - Sharma, Rajan
AU - Tocchetti, Carlo Gabriele
AU - Yilmaz, Mehmet Birhan
AU - Vitale, Cristiana
AU - Volterrani, Maurizio
AU - von Haehling, Stephan
AU - Chioncel, Ovidiu
AU - Coats, Andrew J.S.
AU - Rosano, Giuseppe
N1 - Publisher Copyright:
© 2023 European Society of Cardiology.
PY - 2023/6
Y1 - 2023/6
N2 - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
AB - Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice.
KW - Emergency department visits
KW - Hospitalization
KW - Intensification of oral therapy
KW - Outpatients
KW - Prognosis
KW - Worsening heart failure
UR - http://www.scopus.com/inward/record.url?scp=85159710877&partnerID=8YFLogxK
U2 - 10.1002/ejhf.2874
DO - 10.1002/ejhf.2874
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37208936
AN - SCOPUS:85159710877
SN - 1388-9842
VL - 25
SP - 776
EP - 791
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 6
ER -